Table 4.
Treatment | SEM1 | |||||
---|---|---|---|---|---|---|
Treatment day 0–28 PW | Con | Con | Pro | Pro | AB + ZnO | |
Treatment day 29–56 PW | Con | Pro | Con | Pro | Con | |
D13 PW | ||||||
Bacteroidetes | 32.092 | 32.76 | 34.22 | 34.56 | 51.66*** | 1.748 |
Epsilonbacteraeota | 0.64 | 0.58 | 1.05 | 0.64 | 0.00*** | 0.189 |
Proteobacteria | 1.72 | 2.08 | 2.77 | 2.02 | 0.51* | 0.491 |
Spirochaetes | 4.71 | 2.16 | 4.67 | 5.89 | 0.03*** | 0.814 |
Tenericutes | 0.49 | 0.14 | 0.08*** | 0.26 | 0.00*** | 0.073 |
D27 PW | ||||||
Bacteroidetes | 31.66 | 30.81 | 30.63 | 31.95 | 53.51*** | 1.715 |
Chlamydiae | 0.03 | 0.02 | 0.01 | 0.03 | 0.00* | 0.010 |
Elusimicrobia | 0.03 | 0.07* | 0.26 | 0.24 | 0.00 | 0.078 |
Epsilonbacteraeota | 0.60 | 0.73 | 0.42 | 0.65 | 0.08* | 0.113 |
Kiritimatiellaeota | 0.23 | 0.06 | 0.18 | 0.17 | 0.00*** | 0.046 |
Lentisphaerae | 0.52 | 0.32 | 0.28 | 0.23 | 0.00*** | 0.090 |
Planctomycetes | 0.09 | 0.05 | 0.11 | 0.05 | 0.00*** | 0.021 |
Proteobacteria | 2.60 | 3.63 | 2.49 | 3.45 | 0.58** | 0.543 |
Spirochaetes | 7.35 | 5.02 | 5.15 | 6.83 | 0.28** | 1.231 |
Synergistetes | 0.02 | 0.01 | 0.02 | 0.02 | 0.00*** | 0.004 |
Tenericutes | 0.18 | 0.11 | 0.20 | 0.14 | 0.00*** | 0.041 |
D35 PW | ||||||
Actinobacteria | 0.29 | 0.31 | 0.37 | 0.32 | 0.62** | 0.046 |
Firmicutes | 51.91 | 55.00 | 60.40 | 58.26 | 62.71* | 2.066 |
Kiritimatiellaeota | 0.35 | 0.30 | 0.24 | 0.27 | 0.00*** | 0.080 |
Lentisphaerae | 0.33 | 0.32 | 0.23 | 0.20 | 0.01*** | 0.067 |
Patescibacteria | 0.02 | 0.10* | 0.03 | 0.03 | 0.00 | 0.018 |
Planctomycetes | 0.24 | 0.24 | 0.12 | 0.14 | 0.00*** | 0.044 |
Spirochaetes | 9.19 | 6.55 | 3.11** | 3.99 | 0.23*** | 1.092 |
D55 PW | ||||||
Fibrobacteres | 0.13 | 0.61 | 0.73* | 0.75 | 0.24 | 0.257 |
PW, post-weaning, Con, control; Pro, probiotic; AB + ZnO, antibiotic + zinc oxide.
1Pooled standard error of the mean (SEM).
2Relative abundances for each treatment are normalized with the total-sum scaling method.
Significant differences between treatment groups and the Con/Con group are indicated as: *** (P ≤ 0.001), ** (0.001 < P ≤ 0.01), and * (0.01 < P ≤ 0.05).
No significant differences were observed at D100 PW.
Statistical analysis of amplicon sequence variant (ASV) abundance was performed using DeSeq224 in R version 4.0223, where low abundance ASVs were manually filtered and a false discovery rate (FDR) of < 0.05 was indicative of significant abundance difference between groups. For each taxon, differences between the median abundances of samples in each treatment group compared to the control group (Con/Con) were assessed using the Wilcoxon Rank Sum test of the R package Metacoder25.